The European Commission on Monday approved under the EU Merger Regulation the proposed acquisition of Biomet Inc. by its American counterpart Zimmer Holdings Inc..
Both companies produce orthopaedic implants and related surgical products. The approval is conditional upon a commitments package submitted by Zimmer.
The Commission had concerns that the merger, as initially notified, could have resulted in price increases for a number of orthopaedic implants in the European Economic Area (EEA). The commitments offered by Zimmer remove these concerns.
"Orthopaedic implants affect the mobility and quality of life of thousands of people across Europe. The remedies obtained by the Commission will ensure that patients continue to benefit from sufficient choice and innovation and that healthcare providers enjoy competitive prices." said Margrethe Vestager, the EU's Commissioner in charge of competition policy.